Sp987

MAKING AI LESS “ARTIFICIAL”: PRACTICAL APPLICATIONS OF ARTIFICIAL INTELLIGENCE IN ENDOSCOPY AND MOTILITY

Date
May 8, 2023
Explore related products in the following collection:

Society: AGA

Technology is pervasive and its role in healthcare continues to grow. This session will give attendees hand on tips to consider how three key technological innovations are transforming GI care: artificial intelligence, social media, electronic medical records and new endoscopic technology. Thought leaders in each of these areas will provide practical approaches in each of these areas for the fellow, clinician, educator and practice leader across education, care delivery and care transformation. Advance practice providers will also benefit from these sessions and lend an important perspective to the discussion.

Presenter

Speaker Image for Jason Samarasena
University of California, Irvine

Tracks

Related Products

Thumbnail for MONITORING OF CALPROTECTIN IN INFLAMMATORY BOWEL DISEASE USING A SWEAT BASED WEARABLE DEVICE
MONITORING OF CALPROTECTIN IN INFLAMMATORY BOWEL DISEASE USING A SWEAT BASED WEARABLE DEVICE
Switching from originator to biosimilar infliximab (IFX) is effective and safe. However, data on multiple switching are scarce. The Edinburgh IBD unit has undertaken three switch programmes: (1) Remicade to CT-P13 (2016), (2) CT-P13 to SB2 (2020), and (3) SB2 to CT-P13 (2021)…
Thumbnail for PANEL DISCUSSION
PANEL DISCUSSION
Technology is pervasive and its role in healthcare continues to grow. This session will give attendees hand on tips to consider how three key technological innovations are transforming GI care: artificial intelligence, social media, electronic medical records and new endoscopic technology…
Thumbnail for ENCAPSULATED MICROBIOTA TRANSPLANT THERAPY IMPROVES PARTIAL MAYO SCORES IN ULCERATIVE COLITIS AND INDUCES RAPID ENGRAFTMENT COMPARED TO PLACEBO CONTROL
ENCAPSULATED MICROBIOTA TRANSPLANT THERAPY IMPROVES PARTIAL MAYO SCORES IN ULCERATIVE COLITIS AND INDUCES RAPID ENGRAFTMENT COMPARED TO PLACEBO CONTROL
Switching from originator to biosimilar infliximab (IFX) is effective and safe. However, data on multiple switching are scarce. The Edinburgh IBD unit has undertaken three switch programmes: (1) Remicade to CT-P13 (2016), (2) CT-P13 to SB2 (2020), and (3) SB2 to CT-P13 (2021)…
Thumbnail for HABITUAL MEAT INTAKE IS ASSOCIATED WITH INCREASED RISK OF DISEASE FLARE IN ULCERATIVE COLITIS: INITIAL RESULTS FROM THE PREDICCT STUDY
HABITUAL MEAT INTAKE IS ASSOCIATED WITH INCREASED RISK OF DISEASE FLARE IN ULCERATIVE COLITIS: INITIAL RESULTS FROM THE PREDICCT STUDY
Switching from originator to biosimilar infliximab (IFX) is effective and safe. However, data on multiple switching are scarce. The Edinburgh IBD unit has undertaken three switch programmes: (1) Remicade to CT-P13 (2016), (2) CT-P13 to SB2 (2020), and (3) SB2 to CT-P13 (2021)…